Lintuzumab (SGN-33) is a humanized monoclonal antibody used in the treatment of cancer. The drug had been developed by Seattle Genetics as a treatment...
5 KB (505 words) - 18:25, 12 August 2023
linotroban (INN) linsidomine (INN) lintitript (INN) lintopride (INN) lintuzumab (INN) Liothyronine Sodium liothyronine (INN) Lipidil Lipitor (Pfizer)...
4 KB (273 words) - 06:32, 15 August 2024
(EGRF), ERBB1 HER1 cancer Lilotomab satetraxetan mab mouse CD37 cancer Lintuzumab mab humanized CD33 cancer Lirilumab mab human KIR2D solid and hematological...
136 KB (4,020 words) - 07:14, 15 August 2024
Imgatuzumab§ Inotuzumab ozogamicin Labetuzumab§ Lifastuzumab vedotin§ Lintuzumab§ Lorvotuzumab mertansine§ Lumretuzumab§ Matuzumab§ Milatuzumab§ Naxitamab...
4 KB (241 words) - 13:42, 14 July 2024
Imgatuzumab§ Inotuzumab ozogamicin Labetuzumab§ Lifastuzumab vedotin§ Lintuzumab§ Lorvotuzumab mertansine§ Lumretuzumab§ Matuzumab§ Milatuzumab§ Naxitamab...
3 KB (129 words) - 01:04, 19 July 2023
Imgatuzumab§ Inotuzumab ozogamicin Labetuzumab§ Lifastuzumab vedotin§ Lintuzumab§ Lorvotuzumab mertansine§ Lumretuzumab§ Matuzumab§ Milatuzumab§ Naxitamab...
5 KB (368 words) - 23:51, 17 July 2024